There is a growing body of literature suggesting that antiphospholipid antibodies develop for
a purpose, that they play several key roles in the innate immune response, and are only …

The antiphospholipid syndrome (APS) is characterized by unpredictable, sporadic,
thrombotic events. The cause of the thrombosis is probably multifactorial and may involve …

Like the femme fatale in The Beatles' Rocky Raccoon, antiphospholipid antibodies (aPL)
and the syndrome with which they are associated (thrombosis, recurrent fetal deaths …

The antiphospholipid syndrome (APS) is an autoimmune condition in which a group of
autoantibodies are thought to play a direct role in the pathogenesis of thrombosis, fetal loss …

Antiphospholipid antibodies (APA) are present in a variety of autoimmune disorders,
including systemic lupus erythematosus (SLE) and the antiphospholipid syndrome (APS) …

The antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
an adaptive immune response against self-PL-binding proteins ending in the production of …

The 10th International Congress on Antiphospholipid Antibodies (Sicily, Italy, September 29–
October 3, 2002)(Fig. 1) provided enlightening aspects on the recent developments in …

Despite the strong association between antiphospholipid antibodies (aPL) and thrombosis,
the pathogenic role of aPL in the development of thrombosis has not been fully elucidated …

The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
presence of pathogenic antiphospholipid antibodies (aPL). Since approximately 30 years …

The antiphospholipid syndrome (APS) is the most common acquired thrombophilia. It is
characterized by venous and arterial thrombosis, recurrent pregnancy loss, and various …